Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis
{{output}}
Introduction: The integration of immune checkpoint inhibitors (ICIs) into the management of resectable non-small cell lung cancer (NSCLC) has markedly improved pathological response and survival. However, the effect of ICI-based ... ...
